-
1.
公开(公告)号:US20220409699A1
公开(公告)日:2022-12-29
申请号:US17929572
申请日:2022-09-02
发明人: Eben Tessari , John Paolini
IPC分类号: A61K38/20 , A61K47/68 , A61K38/17 , A61K39/395 , A61P9/00
摘要: The present invention provides, among other things, methods of treating post-cardiac injury syndrome (PCIS) or pericarditis, comprising a step of administering to a subject in need of treatment an interleukin-1 receptor-Fc fusion protein at a therapeutically effective dose and an administration interval for a treatment period sufficient to improve, stabilize or reduce one or more signs and symptoms of pericarditis relative to a control.
-
2.
公开(公告)号:US20220072102A1
公开(公告)日:2022-03-10
申请号:US17527956
申请日:2021-11-16
发明人: Eben Tessari , John Paolini
IPC分类号: A61K38/20 , A61K47/68 , A61K38/17 , A61K39/395 , A61P9/00
摘要: The present invention provides, among other things, methods of treating post-cardiac injury syndrome (PCIS) or pericarditis, comprising a step of administering to a subject in need of treatment an interleukin-1 receptor-Fc fusion protein at a therapeutically effective dose and an administration interval for a treatment period sufficient to improve, stabilize or reduce one or more signs and symptoms of pericarditis relative to a control.
-
3.
公开(公告)号:US20210283224A1
公开(公告)日:2021-09-16
申请号:US17208409
申请日:2021-03-22
发明人: Eben Tessari , John Paolini
IPC分类号: A61K38/20 , A61K47/68 , A61K38/17 , A61K39/395 , A61P9/00
摘要: The present invention provides, among other things, methods of treating post-cardiac injury syndrome (PCIS) or pericarditis, comprising a step of administering to a subject in need of treatment an interleukin-1 receptor-Fc fusion protein at a therapeutically effective dose and an administration interval for a treatment period sufficient to improve, stabilize or reduce one or more signs and symptoms of pericarditis relative to a control.
-
4.
公开(公告)号:US11026997B2
公开(公告)日:2021-06-08
申请号:US16143391
申请日:2018-09-26
发明人: Eben Tessari , John Paolini
IPC分类号: A61K38/20 , A61K47/68 , A61K38/17 , A61P9/00 , A61K39/395
摘要: The present invention provides, among other things, methods of treating post-cardiac injury syndrome (PCIS) or pericarditis, comprising a step of administering to a subject in need of treatment an interleukin-1 receptor-Fc fusion protein at a therapeutically effective dose and an administration interval for a treatment period sufficient to improve, stabilize or reduce one or more signs and symptoms of pericarditis relative to a control.
-
5.
公开(公告)号:US11844765B2
公开(公告)日:2023-12-19
申请号:US18313134
申请日:2023-05-05
发明人: Eben Tessari , John Paolini
IPC分类号: A61K38/20 , A61K47/68 , A61K38/17 , A61P9/00 , A61K39/395
CPC分类号: A61K38/2006 , A61K38/1709 , A61K38/1793 , A61K39/395 , A61K47/68 , A61K47/6811 , A61K47/6813 , A61P9/00
摘要: The present invention provides, among other things, methods of treating post-cardiac injury syndrome (PCIS) or pericarditis, comprising a step of administering to a subject in need of treatment an interleukin-1 receptor-Fc fusion protein at a therapeutically effective dose and an administration interval for a treatment period sufficient to improve, stabilize or reduce one or more signs and symptoms of pericarditis relative to a control.
-
6.
公开(公告)号:US20240293510A1
公开(公告)日:2024-09-05
申请号:US18671801
申请日:2024-05-22
发明人: Eben Tessari , John Paolini
IPC分类号: A61K38/20 , A61K38/17 , A61K39/395 , A61K47/68 , A61P9/00
CPC分类号: A61K38/2006 , A61K38/1709 , A61K38/1793 , A61K39/395 , A61K47/68 , A61K47/6811 , A61K47/6813 , A61P9/00
摘要: The present invention provides, among other things, methods of treating post-cardiac injury syndrome (PCIS) or pericarditis, comprising a step of administering to a subject in need of treatment an interleukin-1 receptor-Fc fusion protein at a therapeutically effective dose and an administration interval for a treatment period sufficient to improve, stabilize or reduce one or more signs and symptoms of pericarditis relative to a control.
-
7.
公开(公告)号:US20230346887A1
公开(公告)日:2023-11-02
申请号:US18313134
申请日:2023-05-05
发明人: Eben Tessari , John Paolini
IPC分类号: A61K38/20 , A61K47/68 , A61K38/17 , A61K39/395 , A61P9/00
CPC分类号: A61K38/2006 , A61K47/68 , A61K47/6811 , A61K38/1793 , A61K38/1709 , A61K39/395 , A61K47/6813 , A61P9/00
摘要: The present invention provides, among other things, methods of treating post-cardiac injury syndrome (PCIS) or pericarditis, comprising a step of administering to a subject in need of treatment an interleukin-1 receptor-Fc fusion protein at a therapeutically effective dose and an administration interval for a treatment period sufficient to improve, stabilize or reduce one or more signs and symptoms of pericarditis relative to a control.
-
8.
公开(公告)号:US20230012740A1
公开(公告)日:2023-01-19
申请号:US17929458
申请日:2022-09-02
发明人: Eben Tessari , John Paolini
IPC分类号: A61K38/20 , A61K47/68 , A61K38/17 , A61K39/395 , A61P9/00
摘要: The present invention provides, among other things, methods of treating post-cardiac injury syndrome (PCIS) or pericarditis, comprising a step of administering to a subject in need of treatment an interleukin-1 receptor-Fc fusion protein at a therapeutically effective dose and an administration interval for a treatment period sufficient to improve, stabilize or reduce one or more signs and symptoms of pericarditis relative to a control.
-
9.
公开(公告)号:US11464830B2
公开(公告)日:2022-10-11
申请号:US17527956
申请日:2021-11-16
发明人: Eben Tessari , John Paolini
IPC分类号: A61K38/20 , A61K47/68 , A61K38/17 , A61P9/00 , A61K39/395
摘要: The present invention provides, among other things, methods of treating post-cardiac injury syndrome (PCIS) or pericarditis, comprising a step of administering to a subject in need of treatment an interleukin-1 receptor-Fc fusion protein at a therapeutically effective dose and an administration interval for a treatment period sufficient to improve, stabilize or reduce one or more signs and symptoms of pericarditis relative to a control.
-
10.
公开(公告)号:US11944666B2
公开(公告)日:2024-04-02
申请号:US17929458
申请日:2022-09-02
发明人: Eben Tessari , John Paolini
IPC分类号: A61K38/20 , A61K38/17 , A61K39/395 , A61K47/68 , A61P9/00
CPC分类号: A61K38/2006 , A61K38/1709 , A61K38/1793 , A61K39/395 , A61K47/68 , A61K47/6811 , A61K47/6813 , A61P9/00
摘要: The present invention provides, among other things, methods of treating post-cardiac injury syndrome (PCIS) or pericarditis, comprising a step of administering to a subject in need of treatment an interleukin-1 receptor-Fc fusion protein at a therapeutically effective dose and an administration interval for a treatment period sufficient to improve, stabilize or reduce one or more signs and symptoms of pericarditis relative to a control.
-
-
-
-
-
-
-
-
-